Teresa Caballero-Velázquez

14PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCardiology (incl. cardiovascular diseases)Transplantation immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 31, 2026
BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

Jose Antonio Bejarano-Garcia, Melanie Nufer, Mª José Palacios-Barea

|Feb 04, 2026
Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Maria Vd Soares, Virginia Escamilla Gómez, Rita I Azevedo

|Jul 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers.

Teresa Caballero-Velázquez, Javier Delgado Serrano, Lucía López-Corral

|Apr 24, 2025
Frontline allo-SCT in MRD-negative, intermediate-risk AML.

Eduardo Rodríguez-Arbolí, Teresa Caballero-Velázquez, Cristina Marrero-Cepeda

|Jun 22, 2024
Monocytosis as prognostic factor for chronic graft versus host disease.

C Marrero-Cepeda, T Caballero-Velazquez, S Garcia-Canale

Pageof 3